|
ZNF740 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.44939948931722E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27509999728426E-09 |
| Normal-vs-Stage2 |
2.137600E-03 |
| Normal-vs-Stage3 |
5.63659996455357E-09 |
| Normal-vs-Stage4 |
1.05209999601286E-08 |
| Stage1-vs-Stage2 |
1.940020E-01 |
| Stage1-vs-Stage3 |
4.581400E-01 |
| Stage1-vs-Stage4 |
1.774990E-01 |
| Stage2-vs-Stage3 |
1.344410E-01 |
| Stage2-vs-Stage4 |
6.561700E-02 |
| Stage3-vs-Stage4 |
5.742400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02190000905722E-09 |
| Normal-vs-AfricanAmerican |
1.004550E-03 |
| Normal-vs-Asian |
4.696099999979E-06 |
| Caucasian-vs-AfricanAmerican |
6.803400E-01 |
| Caucasian-vs-Asian |
5.846600E-01 |
| AfricanAmerican-vs-Asian |
9.356400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.15489999785723E-08 |
| Normal-vs-Female |
7.5018002920757E-10 |
| Male-vs-Female |
9.383400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.23179999533818E-09 |
| Normal-vs-Age(41-60Yrs) |
3.96739999963813E-07 |
| Normal-vs-Age(61-80Yrs) |
1.0278000006636E-08 |
| Normal-vs-Age(81-100Yrs) |
1.623060E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.814600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.184200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.151600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.742600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.614200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.576000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.938890E-03 |
| Classical-VS-Follicular |
4.735000E-01 |
| Classical-VS-Other |
6.781400E-01 |
| Classical-VS-Normal |
4.9653999800725E-09 |
| Tall-VS-Follicular |
1.664080E-02 |
| Tall-VS-Other |
5.524000E-01 |
| Tall-VS-Normal |
2.8197999490942E-10 |
| Follicular-VS-Other |
7.942000E-01 |
| Follicular-VS-Normal |
3.70090000001433E-06 |
| Other-VS-Normal |
1.797680E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58049999976484E-07 |
| Normal-vs-N1 |
1.24770005438535E-09 |
| N0-vs-N1 |
2.057800E-02 |
|
|
